Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-006242-26Phase 2Completed
Phase 2, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Hospital Würzburg. Primary endpoint: Primary fMRI endpoint. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-006242-26.